Metabolic Changes Associated With Weight Gain After Treatment of Achalasia
ConditionAchalasia, Esophageal
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssaf-Harofeh Medical Center
About this trial
This goal of the study is to assess the effect of weight gain in patients with achalasia after they are treated. The main question to be answered is if weight gain after achalasia treatment is associated with worsening metabolic status. Patients will be compared between their baseline status at the time of treatment and 1 year after treatment. Participants will have metabolic tests performed at these 2 times including blood tests.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Proven achalasia
Undergoing LHM or POEM for treatment
Disqualifiers
Under age 18
Does no consent
Trial population
Patients diagnosed with achalasia and undergoing therapy with either POEM or LHM
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
30 Participants
are grouped into 1 trial groupGroup A: Achalasia patients
Trial outcomes
Primary outcomes
1
Increase in Hepatic steatosis
The degree of hepatic steatosis assessed on FibroScan at baseline compared to 1 year later
Time frame
1 yearSecondary outcomes
1
fasting glucose
Change in fasting glucose between baseline and 1 year later
Time frame
1 year2
Hgb A1c
Change in Hgb A1c level between baseline and 1 year later
Time frame
1 year3
Cholesterol
Change in cholesterol between baseline and 1 year later
Time frame
1 year4
Triglycerides
Change in triglycerides between baseline and 1 year later
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Assaf-Harofeh Medical Center
Lead sponsor
Hadassah Medical Organization
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: